S Parrish Winesett, M.D.
Clinical Associate Professor
On This Page
About S Parrish Winesett
Hello, my name is Steven Parrish Winesett, MD, and I am a board-certified pediatric neurologist and pediatric epileptologist. I have extensive experience with complex epilepsy, including pre-surgical evaluations and advanced EED monitoring. I also have expertise in nonpharmagologic treatments for epilepsy, including vagal nerve stimulation and special diets, such as the ketogenic diet and the modified Atkins diet.
I graduated from the University of Florida with a degree in microbiology and received my medical degree from the University of South Florida. I trained in pediatrics and internal medicine at the University of South Florida, child neurology at Vanderbilt University and epilepsy at the University of South Florida.
Teaching Profile
Courses Taught
-
MDC7400 – Pediatric Clerkship
College of Medicine
-
PAS5020 – Intro to Medicine 2
College of Medicine
Board Certifications
-
EpilepsyAmerican Board of Psychiatry and Neurology
-
Neurology with Special Qualification in Child NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Subspecialties
- Pediatric Neurology
Areas of Interest
- Adrenoleukodystrophy
- Epilepsy
- Epilepsy in Children
- Magnetoencephalography (MEG)
- Metachromatic Leukodystrophy
- Tuberous Sclerosis
Publications
Academic Articles
Grants
-
A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (ribitol) in Patients with Limb Girdle Muscular Dystrophy 2I (LGMD2I)
Active
- Role:
- Principal Investigator
- Funding:
- FORTREA via ML BIO SOLUTIONS
-
CTOA
Active
- Role:
- Principal Investigator
- Funding:
- UNIV OF FLORIDA
-
Compassionate Use Program for olipudase alfa enzyme replacement therapy for patients with chronic acid sphingomyelinase deficiency (ASMD)
- Role:
- Principal Investigator
- Funding:
- SANOFI US SERVICES
-
Phase 1b, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Rising Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of VK0214, in Subjects with the Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)
- Role:
- Principal Investigator
- Funding:
- INCLIN INC via VIKING THERAPEUTICS
-
Open Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) in Patients with Fabry Disease
- Role:
- Principal Investigator
- Funding:
- CHIESI FARMACEUTICI
-
Effects of Cannabidol Use on the Developing Brain in Medically Refractory Childhood Epilepsy
- Role:
- Principal Investigator
- Funding:
- FL DEPT OF HLTH REFRACTORY INTRACTABLE E
Education
-
Fellowship, Epilepsy
University of South Florida
-
Master of Business Administration
University of South Florida
-
Residency, Neurology with special competence in Pediatrics
Vanderbilt
-
Combined Internal Medicine/ Pediatrics Residency
University of South Florida
-
Medical Degree
University of South Florida
Contact Details
- Business:
- (352) 273-8920
- Business:
- parrish.winesett@ufl.edu
- Business Mailing:
-
PO Box 100296
GAINESVILLE FL 32610 - Business Street:
-
ARB RG-140
1600 SW Archer Road
Gainesville FL 32610